patent expiration

Pharma

Astellas CEO resists 'rescue BD' as Xtandi patent cliff nears

With Xtandi set to lose U.S. patent protection next year, Astellas’ CEO fielded questions this week about his company’s BD strategy ahead of the loss.

Angus Liu Jan 15, 2026 10:42am

Business development BD growth business growth

BMS, Merck, Amgen and more face near-term generic woes: Leerink

Nov 13, 2024 10:57am

FTC takes aim at 'sham' biopharma patents

Sep 14, 2023 3:55pm

Supreme Court asks Biden administration for 'skinny label' help

Oct 4, 2022 9:59am

Novartis files FDA appeal in bid to block Entresto generics

Sep 16, 2022 11:28am

Gilead settles Descovy patent feuds with 5 drugmakers

Sep 12, 2022 10:05am